Parallel Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-92
Closed -$3.05K 3937
2026
Q1
$3.05K Buy
+92
New +$2.99K ﹤0.01% 3222
2023
Q4
Sell
-100
Closed -$500 3333
2023
Q3
$500 Hold
100
﹤0.01% 3102
2023
Q2
$913 Hold
100
﹤0.01% 2956
2023
Q1
$945 Hold
100
﹤0.01% 2969
2022
Q4
$998 Hold
100
﹤0.01% 2896
2022
Q3
$1K Buy
+100
New +$1K ﹤0.01% 2851
2020
Q4
Sell
-3,002
Closed -$35K 2564
2020
Q3
$35K Hold
3,002
﹤0.01% 1208
2020
Q2
$27K Hold
3,002
﹤0.01% 1290
2020
Q1
$31K Hold
3,002
﹤0.01% 1113
2019
Q4
$54K Hold
3,002
﹤0.01% 1008
2019
Q3
$37K Buy
3,002
+2,971
+9,584% +$48.9K ﹤0.01% 1096
2019
Q2
$1K Hold
31
﹤0.01% 2170
2019
Q1
$1K Buy
+31
New +$566 ﹤0.01% 2158

Other funds holding AXGN

Parallel Advisors's AXGN Position: Q2 2026 in Review

Parallel Advisors sold out of Axogen (AXGN) in Q2 2026, closing a stake of 92 shares — an estimated $3.05K sold.

Parallel Advisors first reported a position in AXGN in Q1 2019 and held it in 13 quarters. The position peaked at $54K in Q4 2019. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Parallel Advisors reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
  • Parallel Advisors sold 92 Axogen shares in Q2 2026, an estimated $3.05K.
  • Parallel Advisors first reported a position in Axogen in Q1 2019 and held it in 13 quarters.
  • Parallel Advisors's Axogen position peaked at $54K in Q4 2019.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.